Abstract:Tongue squamous cell carcinoma (TSCC) accounts for a large proportion of cases of head and neck cancer. Transient receptor potential melastatin 2 (TRPM2) is a non‑selective cation channel sensitive to oxidative stress. High TRPM2 expression has been reported in various types of cancer, including neuroblastoma, glioblastoma, non‑small cell lung cancer and breast cancer. However, whether expression levels of TRPM2 are associated with aggressive clinical features in TSCC remains unclear. A total of 26 clinical sample tissues with TSCC were collected in the present study. The expression levels of the TRPM2 channel were determined by immunohistochemistry, western blot, and qPCR analysis. The content of malondialdehyde (MDA) and the activity of superoxide dismutase (SOD) were measured to reveal oxidative stress levels in TSCC tissues with different degrees of differentiation. The protein expression levels of caspase‑8, Bcl‑xL, Bax, caspase‑9, cleaved caspase‑9, caspase‑3, cleaved caspase‑3, poly [ADP‑ribose] polymerase (PARP) and cleaved PARP were detected by western blot analysis. Analysis of the tissue specimens from 26 patients with TSCC showed that TRPM2 was not upregulated in all specimens. Notably, the expression levels of TRPM2 were associated with the histological grading of different tissues. The specimens with low TRPM2 expression were significantly associated with moderate or poor differentiation (P=0.003), and exhibited increased lipid peroxidation level and decreased SOD activity. Furthermore, the altered expression of pro‑ and anti‑apoptotic proteins indicated a significant upregulation of apoptosis in TSCC tissues with low TRPM2 expression. These results suggested that low TRPM2 expression in TSCC may inhibit the ability of cells to adapt to or resist the oxidative stress, resulting in increased susceptibility to apoptosis. Therefore, the oxidative stress‑sensitive TRPM2 channel may serve as a potent biomarker, and the present study provides insights into the underlying mechanisms of tumor cell differentiation.

Increased Expression of Peroxiredoxin 6 and Cyclophilin A in Squamous Cell Carcinoma of the Tongue.

Decreased Expression Of Bar Is Correlated With Poor Prognosis In Oral And Oropharyngeal Carcinoma

Immunohistochemical Analysis of P57(kip2), P53 and Hsp60 Expressions in Premalignant and Malignant Oral Tissues

High Expression of EphB6 Protein in Tongue Squamous Cell Carcinoma is Associated with a Poor Outcome.

TRPM2 Expression Levels Are Associated with Histological Grading in Patients with Tongue Squamous Cell Carcinoma.

[Expression of Pjak, Perk and Cyclin D1 Proteins in Squamous-Cell Carcinoma of Tongue].

[Expression of Notch1 and Epidermal Growth Factor Receptor in Human Tongue Squamous Cell Carcinoma and Precancerous Lesion].

Overexpression of metabolic markers PKM2 and LDH5 correlates with aggressive clinicopathological features and adverse patient prognosis in tongue cancer

A simple spatial alternation task for assessing memory function in zebrafish

The Clinical and Biological Effects of Receptor Expression-Enhancing Protein 6 in Tongue Squamous Cell Carcinoma

Expression of P53, P16 and Cyclooxygenase-2 in Esophageal Cancer with Tissue Microarray

Downregulation of Notch1 and Its Potential Correlation with Epidermal Growth Factor Receptor Signalling in Tongue Squamous Cell Carcinoma

DNA base excision repair proteins APE-1 and XRCC-1 are overexpressed in oral tongue squamous cell carcinoma

Expressions and significance of autophagy related gene Beclin-1 and apoptosis related gene Bcl-2 in tongue squamous cell carcinoma

Increased levels of CK19 mRNA in oral squamous cell carcinoma tissue detected by relative quantification with real-time polymerase chain reaction.

mRNA expression of the DNA replication-initiation proteins in epithelial dysplasia and squamous cell carcinoma of the tongue

An Integrated Analysis of Prognostic Signature and Immune Microenvironment in Tongue Squamous Cell Carcinoma

The Mammalian Target of Rapamycin-70-kDa Ribosomal Protein S6 Kinase Axis Inhibits the Biological Function of Tongue Squamous Cell Carcinoma.

Overexpression of Hippo Pathway Effector TAZ in Tongue Squamous Cell Carcinoma: Correlation with Clinicopathological Features and Patients' Prognosis.

The interaction of PRDX1 with Cofilin promotes oral squamous cell carcinoma metastasis

Increased HOXC6 Expression Predicts Chemotherapy Sensitivity in Patients with Esophageal Squamous Cell Carcinoma.